Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

Johnson SK, Heuck CJ, Albino AP, Qu P, Zhang Q, Barlogie B, Shaughnessy JD Jr.

Int J Hematol. 2011 Oct;94(4):321-333. doi: 10.1007/s12185-011-0948-y. Epub 2011 Oct 15. Review.

2.

DNA damage response induced by exposure of human lung adenocarcinoma cells to smoke from tobacco- and nicotine-free cigarettes.

Jorgensen ED, Zhao H, Traganos F, Albino AP, Darzynkiewicz Z.

Cell Cycle. 2010 Jun 1;9(11):2170-6. Epub 2010 Jun 1.

3.

Fluorescent detection of lipid peroxidation derived protein adducts upon in-vitro cigarette smoke exposure.

Rainey RP, Gillman IG, Shi X, Cheng T, Stinson A, Gietl D, Albino AP.

Toxicol Mech Methods. 2009 Sep;19(6-7):401-9. doi: 10.1080/15376510903104224.

PMID:
19778240
4.

DNA damage response induced by tobacco smoke in normal human bronchial epithelial and A549 pulmonary adenocarcinoma cells assessed by laser scanning cytometry.

Zhao H, Albino AP, Jorgensen E, Traganos F, Darzynkiewicz Z.

Cytometry A. 2009 Oct;75(10):840-7. doi: 10.1002/cyto.a.20778.

5.

Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes.

Drgon T, Johnson C, Walther D, Albino AP, Rose JE, Uhl GR.

Mol Med. 2009 Jul-Aug;15(7-8):268-74. doi: 10.2119/molmed.2009.00040. Epub 2009 Apr 29.

6.

gammaH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco products.

Albino AP, Jorgensen ED, Rainey P, Gillman G, Clark TJ, Gietl D, Zhao H, Traganos F, Darzynkiewicz Z.

Mutat Res. 2009 Aug;678(1):43-52. doi: 10.1016/j.mrgentox.2009.06.009. Epub 2009 Jul 8.

7.

Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells.

Jorgensen E, Stinson A, Shan L, Yang J, Gietl D, Albino AP.

BMC Cancer. 2008 Aug 11;8:229. doi: 10.1186/1471-2407-8-229.

8.

A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.

Becker KM, Rose JE, Albino AP.

Nicotine Tob Res. 2008 Jul;10(7):1139-48. doi: 10.1080/14622200802123294.

PMID:
18629723
9.

Oxidative stress induces cell cycle-dependent Mre11 recruitment, ATM and Chk2 activation and histone H2AX phosphorylation.

Zhao H, Traganos F, Albino AP, Darzynkiewicz Z.

Cell Cycle. 2008 May 15;7(10):1490-5. Epub 2008 Mar 18.

10.

Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.

Tanaka T, Huang X, Halicka HD, Zhao H, Traganos F, Albino AP, Dai W, Darzynkiewicz Z.

Cytometry A. 2007 Sep;71(9):648-61. Review.

11.

ATM activation accompanies histone H2AX phosphorylation in A549 cells upon exposure to tobacco smoke.

Tanaka T, Huang X, Jorgensen E, Gietl D, Traganos F, Darzynkiewicz Z, Albino AP.

BMC Cell Biol. 2007 Jun 26;8:26.

12.

Induction of colon tumorigenesis by glutathione depletion in p53-knock-out mice.

Richie JP Jr, Komninou D, Albino AP.

Int J Oncol. 2007 Jun;30(6):1539-43.

PMID:
17487376
13.

Induction of DNA double-strand breaks in A549 and normal human pulmonary epithelial cells by cigarette smoke is mediated by free radicals.

Albino AP, Huang X, Jorgensen ED, Gietl D, Traganos F, Darzynkiewicz Z.

Int J Oncol. 2006 Jun;28(6):1491-505.

PMID:
16685450
14.

Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.

Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.

Mol Carcinog. 2006 Jan;45(1):26-37. Erratum in: Mol Carcinog. 2006 Jul;45(7):549. Aggarwal, Bharat A [corrected to Aggarwal, Bharat B].

PMID:
16267831
15.

Global gene expression analysis of human bronchial epithelial cells treated with tobacco condensates.

Jorgensen ED, Dozmorov I, Frank MB, Centola M, Albino AP.

Cell Cycle. 2004 Sep;3(9):1154-68. Epub 2004 Sep 10.

PMID:
15326394
16.

Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke: a new assay for carcinogens.

Albino AP, Huang X, Jorgensen E, Yang J, Gietl D, Traganos F, Darzynkiewicz Z.

Cell Cycle. 2004 Aug;3(8):1062-8. Epub 2004 Aug 24.

PMID:
15254392
17.

Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?

Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP.

Melanoma Res. 2001 Aug;11(4):355-69.

PMID:
11479424
18.

Update of diagnostic and prognostic markers in cutaneous malignant melanoma.

Reed JA, Albino AP.

Clin Lab Med. 2000 Dec;20(4):817-38. Review.

PMID:
11221516
19.

Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.

Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP, Darzynkiewicz Z.

Cancer Res. 2000 Aug 1;60(15):4139-45.

20.
21.

A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.

Wesley UV, Albino AP, Tiwari S, Houghton AN.

J Exp Med. 1999 Aug 2;190(3):311-22.

22.

Update of diagnostic and prognostic markers in cutaneous malignant melanoma.

Reed JA, Albino AP.

Dermatol Clin. 1999 Jul;17(3):631-43. Review.

PMID:
10410863
24.

Chemotherapy and P-glycoprotein expression in chondrosarcoma.

Terek RM, Schwartz GK, Devaney K, Glantz L, Mak S, Healey JH, Albino AP.

J Orthop Res. 1998 Sep;16(5):585-90.

PMID:
9820282
25.

Reversal of the low-affinity neurotrophin receptor stromal-epithelial expression pattern between benign and malignant human prostate.

Papandreou CN, Bogenrieder T, Finstad CL, Freeman RH, Chao MV, Albino AP, Scher HI, Reuter VE, Nanus DM.

Urol Oncol. 1998 Nov-Dec;4(6):210-7.

PMID:
21227260
26.

Aminopeptidase A expression and enzymatic activity in primary human renal cancers.

Nanus DM, Bogenrieder T, Papandreou CN, Finstad CL, Lee A, Vlamis V, Motzer RJ, Bander NH, Albino AP, Reuter VE.

Int J Oncol. 1998 Aug;13(2):261-7.

PMID:
9664120
27.

p53 mutations in chondrosarcoma.

Terek RM, Healey JH, Garin-Chesa P, Mak S, Huvos A, Albino AP.

Diagn Mol Pathol. 1998 Feb;7(1):51-6.

PMID:
9646035
28.

Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.

Albino AP, Reed JA, Bogdany JK, Sassoon J, Parisier SC.

Am J Otol. 1998 May;19(3):266-72. Review.

PMID:
9596172
29.

Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas.

Geng Y, Biffi A, Engelstein D, Ronch E, Faustini M, Lai HK, Albino AP, Di Fronzo G, Nanus DM.

Anticancer Res. 1998 Jan-Feb;18(1A):1-7.

PMID:
9568047
30.

The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions.

Khare VK, Albino AP, Reed JA.

J Cutan Pathol. 1998 Jan;25(1):2-10.

PMID:
9508337
31.

Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.

Albino AP, Reed JA, Bogdany JK, Sassoon J, Desloge RB, Parisier SC.

Am J Otol. 1998 Jan;19(1):30-6.

PMID:
9455944
32.

Cholesteatoma: a molecular and cellular puzzle.

Albino AP, Kimmelman CP, Parisier SC.

Am J Otol. 1998 Jan;19(1):7-19. Review.

PMID:
9455941
33.

Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.

Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM.

Nat Med. 1998 Jan;4(1):50-7.

PMID:
9427606
34.

Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue.

Bogenrieder T, Finstad CL, Freeman RH, Papandreou CN, Scher HI, Albino AP, Reuter VE, Nanus DM.

Prostate. 1997 Dec 1;33(4):225-32.

PMID:
9397193
35.

Loss of heterozygosity and homozygous deletion of the tpr locus in human gastric cancer.

Cunningham JD, Schwartz GK, Karpeh M, Blundell M, Kelson DP, Jhanwar SC, Albino AP.

Am J Surg. 1997 Jun;173(6):521-2.

PMID:
9207167
36.

Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells.

Bocchia M, Xu Q, Wesley U, Xu Y, Korontsvit T, Loganzo F, Albino AP, Scheinberg DA.

Leuk Res. 1997 May;21(5):439-47.

PMID:
9225073
37.

Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers.

Papandreou CN, Bogenrieder T, Loganzo F, Albino AP, Nanus DM.

Urology. 1997 Mar;49(3):481-6.

PMID:
9123723
38.

DNA analysis of human cholesteatomas.

Desloge RB, Carew JF, Finstad CL, Steiner MG, Sassoon J, Levenson MJ, Staiano-Coico L, Parisier SC, Albino AP.

Am J Otol. 1997 Mar;18(2):155-9.

PMID:
9093669
39.

Altered regulation of cell surface peptidases in human cholesteatoma.

Desloge RB, Finstad CL, Sassoon J, Han JC, Parisier SC, Albino AP.

Otolaryngol Head Neck Surg. 1997 Jan;116(1):58-63. Erratum in: Otolaryngol Head Neck Surg 1997 Mar;116(3):418.

PMID:
9018259
41.

Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions.

Pfeffer LM, Wang C, Constantinescu SN, Croze E, Blatt LM, Albino AP, Nanus DM.

J Urol. 1996 Nov;156(5):1867-71.

PMID:
8863634
42.

Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma.

Papandreou C, Bogenrieder T, Loganzo F, Chao MV, Nanus DM, Albino AP.

Melanoma Res. 1996 Oct;6(5):373-8.

PMID:
8908597
43.

Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.

Hoffman AD, Engelstein D, Bogenrieder T, Papandreou CN, Steckelman E, Dave A, Motzer RJ, Dmitrovsky E, Albino AP, Nanus DM.

Clin Cancer Res. 1996 Jun;2(6):1077-82.

44.

Oncogenes and tumor suppressor genes in cutaneous malignant melanoma.

Albino AP, Fountain JW.

Photochem Photobiol. 1996 Apr;63(4):412-8. Review. No abstract available.

PMID:
8934752
45.

Expression of the retinoblastoma gene product in renal tumors.

Presti JC Jr, Reuter VE, Cordon-Cardo C, Motzer RJ, Albino AP, Jhanwar SC, Nanus DM.

Anticancer Res. 1996 Mar-Apr;16(2):549-56.

PMID:
8687097
46.

Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.

Glendening JM, Flores JF, Walker GJ, Stone S, Albino AP, Fountain JW.

Cancer Res. 1995 Dec 1;55(23):5531-5.

47.

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.

Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F Jr, Kelsen DP, Fuks Z, Albino AP.

J Natl Cancer Inst. 1995 Sep 20;87(18):1394-9.

PMID:
7658500
48.

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.

Motzer RJ, Schwartz L, Law TM, Murphy BA, Hoffman AD, Albino AP, Vlamis V, Nanus DM.

J Clin Oncol. 1995 Aug;13(8):1950-7.

PMID:
7636535
49.

Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas.

Vidal MJ, Loganzo F Jr, de Oliveira AR, Hayward NK, Albino AP.

Melanoma Res. 1995 Aug;5(4):243-50.

PMID:
7496159
50.

Genes involved in melanoma susceptibility and progression.

Albino AP.

Curr Opin Oncol. 1995 Mar;7(2):162-9. Review.

PMID:
7538793

Supplemental Content

Loading ...
Support Center